AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals
Biotech firm Recursion to buy smaller peer Exscientia for $688 million
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance